UCB.
biopharmaceutical company headquartered in Brussels, Belgium
- Reports this week
- 2
- Active events
- 1
- Connections
- 108
What's happening
Earlier this month
-
Sanofi eliminated INOV investment value, while Ipsen and UCB acquired INOV portfolio companies.Some support1 report
-
Trump's tariffs led to price spikes and inflation, while FED policy uncertainty affected market volatility and investor decisions for companies like Martin Marietta Materials and UCB.Well supported6 reports8 developments inside
One to three months ago
-
Negotiated prices are impacting market access and revenue for major pharmaceutical companies like Pfizer, UCB, Bristol-Myers Squibb, and Novartis.Some support1 report
-
UCB operates offices and manages an SBA lending franchise across multiple Southern states, including Alabama, Georgia, and Florida.Some support1 report1 development inside
-
UCB is expanding its presence in Georgia by building a new biomanufacturing campus in the Atlanta metro area.Some support2 reports
-
UCB is developing products globally.Some support2 reports
-
The FDA approved FINTEPLA for the treatment of rare epilepsy.Some support1 report
-
Investment bank issues rating upgrades for UCB, while an analyst firm raises the outlook on the company's stock.Some support4 reports
-
Selling portfolios could reduce net interest margin, driven by a pending Navitas sale.Some support2 reports
Gone quiet
No new reports in 90+ days-
Jerome Powell's dovish signal on August 23, 2025, suggesting potential interest rate cuts relevant to Morgan Stanley.Well supported39 reports6 developments inside
-
Lizzo's remix sampled UCB's hit track. Wale was noted as a DMV native, and he also hosted events featuring Nino Paid and Gogo.Some support1 report
-
UCB, a company founded in Belgium in 1928 and headquartered in Brussels, has seen its shares upgraded in recent research notes.Some support11 reports
-
Hansa Biopharma, Chiesi, and UCB participated in life sciences discussions in Lisbon.Some support1 report
-
UCB utilizes Depository Trust Company (DTC) services for corporate actions, specifically for holding preferred stock and managing share redemptions.Some support1 report
-
Samara Ferguson's career history reveals she worked at Amgen, GSK, and UCB for over 20 years, culminating in a VP appointment to lead Pricing and Market Access.Some support1 report
-
UCB, Eisai, Lundbeck, and GW Pharmaceuticals are identified as key players in a market supported by supportive FDA policies.Some support1 report
-
UCB (Q902046) experienced stock price movement following an upgrade on August 27, 2025, driven by positive earnings outlook and institutional investor activity.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around UCB this week
News at the entities that move UCB most-
SBA StructuralFinWise benefited from growth in SBA 7A loans.Moves UCB
-
Donald Trump TransactionalThe Trump administration utilized the Department of Health & Human Services for an AI tool.Moves UCB
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves UCB
-
Medicare StructuralLeaders call for slowing AI development pace, concurrent with an AI model built by OpenAI being hacked via the Medicare portal.Moves UCB
-
TD Cowen TransactionalAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves UCB
-
Florida Shared contextThe article covers three concurrent stories: Brightline facing financial strain, FPL offering bill credits to seniors, and Florida's wage hike attracting workers from Alabama.Moves UCB
Connections
The 28 strongest of 108, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SBA Structural
UCB operates as a national lending franchise under the SBA framework.
-
Navitas Transactional
A pending sale by Navitas was observed to drive a reserve release by UCB.
-
Lizzo Transactional
Lizzo incorporated a track from UCB into her own remix work.
-
Donald Trump Transactional
Donald Trump secured drug-pricing agreements and inclusion plans involving UCB.
-
FDA Structural
FDA regulates UCB's drug products, as evidenced by the approval of FINTEPLA for rare epilepsy treatments.
-
Medicare Structural
Medicare exercises regulatory power over UCB through negotiated prices, which directly impacts its market access and revenue.
-
Florida Shared context
UCB operates offices within the geographic and legal context of the state of Florida.
-
MarketBeat Mentioned together
MarketBeat aggregates and tracks financial data and analyst ratings for UCB stock.
Show all 28 connections
-
Georgia Shared context
UCB operates offices and builds manufacturing facilities within the geographical context of Georgia.
-
Tennessee Shared context
UCB operates offices within the geographical boundaries of Tennessee.
-
Alabama Shared context
UCB maintains operational offices within the state of Alabama.
-
Forbes Mentioned together
Forbes has named UCB among its selections for best banks.
-
Chiesi Mentioned together
The entities are co-mentioned as participants in broader life sciences industry discussions.
-
Southeast Shared context
UCB operates and expands within the regional market context of Southeast.
-
M&T Bank Shared context
Both entities operate as regional banks within a shared market segment.
-
Commerce Bancshares Mentioned together
Both entities are characterized as regional banks within the same market segment.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides financial research notes and analyst ratings covering UCB's stock performance.
-
Alcon Mentioned together
Both Alcon and UCB are cited as members of a cohort of nine manufacturers.
-
AstraZeneca Mentioned together
The entities are co-mentioned as founding members of the Clean Heat Program.
-
Brussels Shared context
UCB is headquartered and operates from Brussels.
-
South Carolina Shared context
UCB maintains operational offices within the borders of South Carolina.
-
North Carolina Shared context
UCB operates offices within the geographical context of North Carolina.
-
Keefe, Bruyette & Woods Mentioned together
A financial services firm provides market coverage and outlook raises for UCB.
-
Lisbon Shared context
UCB was observed participating in an event held in Lisbon.
-
Belgium Shared context
UCB is a biopharmaceutical company headquartered in Belgium.
-
Greenville Shared context
UCB operates and maintains offices within the Greenville, South Carolina region.
-
Atlanta Shared context
UCB maintains its headquarters in metro Atlanta.
-
TD Cowen Transactional
TD Cowen, an investment bank, issued rating upgrades for UCB.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
4 events- Negotiated prices are impacting market access and revenue for major pharmaceutical companies like Pfizer, UCB, Bristol-Myers Squibb, and Novartis.
- UCB is expanding its presence in Georgia by building a new biomanufacturing campus in the Atlanta metro area.
- UCB is developing products globally.
- The FDA approved FINTEPLA for the treatment of rare epilepsy.
July 2026
2 eventsShow 1 earlier month
June 2026
11 events- UCB expanded through acquisitions across the Southeast and provides services across the southeastern United States.
- Trump's tariffs led to price spikes and inflation, while FED policy uncertainty affected market volatility and investor decisions for companies like Martin Marietta Materials and UCB.
- UCB operates offices and manages an SBA lending franchise across multiple Southern states, including Alabama, Georgia, and Florida.
- Jerome Powell's dovish signal on August 23, 2025, suggesting potential interest rate cuts relevant to Morgan Stanley.
- Lizzo's remix sampled UCB's hit track. Wale was noted as a DMV native, and he also hosted events featuring Nino Paid and Gogo.
- UCB, a company founded in Belgium in 1928 and headquartered in Brussels, has seen its shares upgraded in recent research notes.
- Hansa Biopharma, Chiesi, and UCB participated in life sciences discussions in Lisbon.
- UCB utilizes Depository Trust Company (DTC) services for corporate actions, specifically for holding preferred stock and managing share redemptions.
- Samara Ferguson's career history reveals she worked at Amgen, GSK, and UCB for over 20 years, culminating in a VP appointment to lead Pricing and Market Access.
- UCB, Eisai, Lundbeck, and GW Pharmaceuticals are identified as key players in a market supported by supportive FDA policies.
- UCB (Q902046) experienced stock price movement following an upgrade on August 27, 2025, driven by positive earnings outlook and institutional investor activity.